Prostate cancer, PSA, and questions that can only be answered by clinical trials - The Moul/Banez/Freedland article reviewed

被引：0
|
作者：
Ward, John F. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Urol, Houston, TX 77030 USA
来源：
ONCOLOGY-NEW YORK | 2007年 / 21卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1452 / +
页数：2
相关论文
共 22 条
  • [1] Biochemical failure in prostate cancer: Managing patients with limited data - The Moul/Banez/Freedland article reviewed
    Dreicer, Robert
    ONCOLOGY-NEW YORK, 2007, 21 (12): : 1449 - +
  • [2] PSA after radiation for prostate cancer - The Kuban/Thames/Levy article reviewed
    Roach, Mack, III
    ONCOLOGY-NEW YORK, 2004, 18 (05): : 605 - +
  • [3] Putting Lung Cancer Clinical Trials Into Perspective The Dowell article reviewed
    Dowell, Jonathan E.
    Schiller, Joan H.
    ONCOLOGY-NEW YORK, 2011, 25 (01): : 78 - 80
  • [4] Advanced Prostate Cancer: New Agents, New Questions THE RUCH AND HUSSAIN ARTICLE REVIEWED
    Dorff, Tanya B.
    Pinski, Jacek
    ONCOLOGY-NEW YORK, 2011, 25 (06): : 509 - 512
  • [5] Multi-center clinical trials for peritoneal mesothelioma: Can they be done and what are the questions to be answered?
    Hassan, R.
    LUNG CANCER, 2006, 54 : S32 - S32
  • [6] Clinical trials in older adults with cancer: Past and future - The Hurria article reviewed
    Extermann, Martine
    ONCOLOGY-NEW YORK, 2007, 21 (03): : 364 - +
  • [7] Prostate-specific antigen (PSA) as a surrogate end point for survival in prostate cancer clinical trials
    Collette, Laurence
    EUROPEAN UROLOGY, 2008, 53 (01) : 6 - 9
  • [8] Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
    Fleming, Mark T.
    Morris, Michael J.
    Heller, Glenn
    Scher, Howard I.
    NATURE CLINICAL PRACTICE ONCOLOGY, 2006, 3 (12): : 658 - 667
  • [9] Post-therapy changes in PSA as an outcome measure in prostate cancer clinical trials
    Mark T Fleming
    Michael J Morris
    Glenn Heller
    Howard I Scher
    Nature Clinical Practice Oncology, 2006, 3 : 658 - 667
  • [10] Systemic therapy for lung cancer brain metastases: A rationale for clinical trials - The Oh/Stewart article reviewed
    Goodgame, Boone
    Govindan, Ramaswamy
    ONCOLOGY-NEW YORK, 2008, 22 (02): : 178 - +
123